Table 2.
MCH and the raphe nuclei.
Substance | Site | Strategies | Main effect | References |
---|---|---|---|---|
MCH | DR | Microinjection and sleep recording | Increases REM sleep. Moderate increases in NREM sleep | Lagos et al., 2009 |
Anti-MCH antibody | DR | Microinjection and sleep recording | Decreases REM sleep. Increases wakefulness | Lagos et al., 2011a |
MCH | DR | Microinjection, FST | Increases immobility time. This effect is blocked by systemic administration of fluoxetine and nortriptyline | Lagos et al., 2011b; Urbanavicius et al., 2015a |
Anti-MCH antibody | DR | Microinjection, FST | Decreases immobility time | Lagos et al., 2011b |
MCHR1 antagonist (ATC0175) | DR | Microinjection, FST | Reverts the pro-depressive effect of microinjections of MCH into the DR | Urbanavicius et al., 2015a |
MCH | MR | Microinjection, FST | Increases immobility time | López Hill et al., 2013 |
MCH | DR | Unit recording, intraventricular and juxtacellular administration of MCH | Inhibit serotonergic and non-serotonergic neurons | Devera et al., 2015 |
MCH | DR | Microdialysis of serotonin, local perfusion of MCH | At low doses decreases serotonin release | Urbanavicius et al., 2013, 2015b |
All the experiments were performed in rats. FST, forced swimming test.